JPWO2019203255A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019203255A5
JPWO2019203255A5 JP2020514407A JP2020514407A JPWO2019203255A5 JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5 JP 2020514407 A JP2020514407 A JP 2020514407A JP 2020514407 A JP2020514407 A JP 2020514407A JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5
Authority
JP
Japan
Prior art keywords
cancer
cells
administration
emt
anticancer drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020514407A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019203255A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/016421 external-priority patent/WO2019203255A1/ja
Publication of JPWO2019203255A1 publication Critical patent/JPWO2019203255A1/ja
Publication of JPWO2019203255A5 publication Critical patent/JPWO2019203255A5/ja
Pending legal-status Critical Current

Links

JP2020514407A 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法 Pending JPWO2019203255A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018080585 2018-04-19
JP2018080585 2018-04-19
PCT/JP2019/016421 WO2019203255A1 (ja) 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法

Publications (2)

Publication Number Publication Date
JPWO2019203255A1 JPWO2019203255A1 (ja) 2021-06-10
JPWO2019203255A5 true JPWO2019203255A5 (cg-RX-API-DMAC7.html) 2022-03-02

Family

ID=68238962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020514407A Pending JPWO2019203255A1 (ja) 2018-04-19 2019-04-17 再構成癌組織を用いた薬剤評価方法

Country Status (2)

Country Link
JP (1) JPWO2019203255A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019203255A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021221179A1 (ja) * 2020-04-28 2021-11-04 国立大学法人高知大学 ヒト膵癌オルガノイドを用いたマウスモデルの樹立
EP4174171A4 (en) 2020-06-25 2024-03-27 Next & Bio Inc. Method for mass proliferation of stem cells without using hydrogel
US12606783B2 (en) 2020-06-25 2026-04-21 Next & Bio Inc. Well plate and 3D culture plate comprising the same
WO2021261625A1 (ko) * 2020-06-25 2021-12-30 주식회사 넥스트앤바이오 암을 가진 대상체의 항암제 및/또는 방사선 내성 진단에 필요한 정보를 제공하는 방법
KR102746470B1 (ko) 2021-07-09 2024-12-26 주식회사 넥스트앤바이오 가상 오가노이드 생성 방법
KR102746473B1 (ko) 2021-07-09 2024-12-26 주식회사 넥스트앤바이오 가상 오가노이드를 이용한 촬영 이미지 데이터 생성 방법
WO2023238939A1 (ja) * 2022-06-09 2023-12-14 慶應義塾 癌の再燃若しくは再発の予防剤又は治療剤及びそのスクリーニング方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2900969A1 (en) * 2013-03-15 2014-09-25 Oncomed Pharmaceuticals, Inc. Methods of treating pancreatic cancer
WO2015153997A2 (en) * 2014-04-04 2015-10-08 Oncomed Pharmaceuticals, Inc. Notch3 antibodies and uses thereof
WO2016089208A2 (en) * 2014-12-04 2016-06-09 Stichting Maastricht Radiation Oncology "Maastro-Clinic" Sulfonamide, sulfamate and sulfamide derivatives of anti-cancer agents

Similar Documents

Publication Publication Date Title
Sun et al. Therapeutic strategies targeting cancer stem cells and their microenvironment
Shanmugam et al. Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis
Jiang et al. Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression
Ribatti The Chick Embryo Chorioallantoic Membrane in the Study of Angiogenesis and Metastasis: The CAM assay in the study of angiogenesis and metastasis
Dang et al. Local doxorubicin delivery via 3D‐printed porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice
Cheikh et al. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
EP3750540A1 (en) Choroidal neovascularization suppressor or drusen formation suppressor
JP2008536487A5 (cg-RX-API-DMAC7.html)
Liu et al. Sustained Release of Nitric Oxide‐Mediated Angiogenesis and Nerve Repair by Mussel‐Inspired Adaptable Microreservoirs for Brain Traumatic Injury Therapy
Shin et al. Immunomodulatory effects of perioperative dexmedetomidine in ovarian cancer: an in vitro and xenograft mouse model study
Qian et al. Ginsenosides: an immunomodulator for the treatment of colorectal cancer
Zhao et al. IKK inhibition prevents PM2. 5-exacerbated cardiac injury in mice with type 2 diabetes
He et al. Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling
Naghinezhad PI3K/AKT/mTOR pathway in ATLL: from basic biology to preclinical study
Khanal et al. Current insights of the potential plant bioactive compounds on modulating the mTOR signaling pathway in regulating oncological disorders
Yin et al. Nourishment of nerves and innervation: A novel approach for the treatment of myocardial infarction
Cutter et al. Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases
DK2919791T3 (da) Delphinidin-kompleks som antiflogistisk eller immunsuppressivt aktivt stof
Ansari et al. Targeting breast cancer signaling via phytomedicine and nanomedicine
Xu et al. Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes
Ji et al. Remodeling the tumor microenvironment: regulatory effects of β-sitosterol and luteolin on the immunosuppressive milieu in endometrial carcinoma and implications for combinatorial immunotherapy
Yoon et al. Effects of drying process for amorphous waxy maize starch on theophylline release from starch‐based tablets
JP2014221752A (ja) ガン幹細胞に対する分化促進薬及び脳腫瘍治療薬
Stephen et al. A comparative study of once daily versus twice daily tacrolimus in liver transplantation
Sailo et al. Molecular alterations involved in pancreatic cancer chemoresistance and chemosensitization strategies